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ABSTRACT

frequency of contact in the cohort. Older children

Background: The purpose of this study is to assess

and children with longer duration of pump use had

if a relationship exists between A1c within target

fewer contacts with low rates of self-directed pump

(≤ 7.5%) and frequency of patient-initiated contact

adjustments. These results raise the importance of

with diabetes team, in children with type 1 diabetes

defining strategies to increase patient engagement

(T1DM) on an insulin pump. Additionally, to determine

and empower diabetes data review. (Clin Diabetol

factors impacting frequency of contact.

2022, 11; 1: 6–10)

Methods: This was a retrospective study of children
with T1DM on an insulin pump. Frequency of contact,

Keywords: type 1 diabetes, insulin pumps, pediatric,

type of contact, and A1c were collected. Study partici-

contact, A1c

pants filled out a questionnaire at study entry.
Results: One hundred and seventy-six participants were
enrolled, with a mean age of 13 years. The median duration of T1DM was 6 years with a median duration of
pump use, 3.6 years. One hundred and sixteen subjects
(66%) contacted the diabetes team for insulin dose adjustments between clinic visits with a mean (standard
deviation [SD]) of 1.2 (± 1.7) contacts, 90% of which
were by e-mail. There was no significant relationship
between achieving target A1c and frequency of contact. However, increasing age and longer duration of
pump use were associated with decreased frequency
of contact. Common barriers to contact included being too busy and technical problems with software.
Conclusions: There was no significant relationship
between the frequency of patient-initiated contact
with diabetes team and A1c. Overall, there was low
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Introduction
Routine management of type 1 diabetes mellitus
(T1DM) requires daily administration of insulin and
frequent glucose monitoring. Technology to support
diabetes self-care has advanced significantly and includes insulin pump therapy, “smart” blood glucose
meters, continuous glucose monitoring, and flash glucose monitoring. A unique feature of these resources
is the ability to download data from insulin pumps,
meters, and continuous glucose monitors instead of
recording data in a logbook. This enables patients and
health care providers to visually assess glycemic trends
and make appropriate insulin changes to optimize
glycemic control. Although these technologies are available, research shows they are underutilized by patients
[1–3]. Thirty-three percent of adolescents with T1DM
were non-adherent in downloading and communica
ting weekly blood sugars to health care providers in
a randomized control trial assessing the effectiveness of
a blood glucose monitoring system [2]. When emphasis
was placed on caregivers, only 56% of caregivers of children in a cross-sectional survey reported downloading
data from one or more diabetes devices at home [3].
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The Diabetes Control and Complications Trial Research Group, a randomized control trial with a mean
follow up of 6.5 years, showed a 35–76% reduction in
early stages of microvascular disease in patients receiving intensive diabetes treatment with a median A1c
of 7% in the intensive treatment group in comparison
to 9% median A1c in the control group [4, 5]. The
majority of study participants were adults; however,
a sub-analysis of the 195 adolescents showed similar
results with a reduction in long-term sequelae of diabetes complications in the intensive treatment group
compared to the control group [6]. This sub-analysis
described the adolescents in the intensive treatment
group having regular monthly visits at their diabetes
clinic, as well as several telephone contacts between
clinic visits [6]. The frequent contact with the health
care team allowed close monitoring and titration of
insulin dosing, promoting A1c within target [6]. Subsequent research studies with less intensive contact have
also shown improvement in glycemic control when
T1DM patients contacted their health care providers
between clinic visits. A randomized controlled trial that
assessed the impact of internet-based blood glucose
upload methods on adolescents with T1DM using an
insulin pump found a significant decrease in A1c in
patients who communicated with their team minimum
of once a month [1].
Most studies that have demonstrated a positive
impact of team communication on glycemic control
are prospective with active intervention of contact with
the diabetes team. We are interested in performing
a real-world study in our pediatric diabetes clinic cohort
to determine the frequency of contact and to assess
if a relationship exists between frequency of contact
and optimal glycemic control. The primary objective
was to assess if there was a relationship between A1c
within target (≤ 7.5%) and frequency of contact with
the diabetes team between clinic visits in children
and adolescents with T1DM. We hypothesized that
increased frequency of contact with the diabetes team
would be positively correlated with A1c within target
(≤ 7.5%). Secondary objectives were to determine
factors impacting frequency of contact and change in
A1c from baseline to end of study. Variables of interest
potentially impacting frequency of contact were age,
duration of pump use, and distance from the hospital.

Methods
This was a retrospective chart review assessing
study participants’ patient-initiated contact with their
diabetes team and glycemic control over one year. Patients with T1DM using insulin pump therapy for one
year or longer, attending the Pediatric Diabetes Clinic

at Children’s Hospital, London Health Sciences Centre
were recruited to participate in the study. Children
not on pump therapy or with oncological diagnoses
were excluded. Data was collected from September
2017 to October 2019. The study was approved by
the Human Research Ethics review board at Western
University and informed consent was obtained from
all study participants.
Study participants were divided into two groups:
A1c within target and A1c not within target. A1c
within target was defined as hemoglobin A1c ≤ 7.5%
as per the Canadian Diabetes Association guideline
and International Society for Pediatrics and Adolescent
Diabetes [7, 8].
Over the one-year study period, there were four
data collection time points: baseline and then every
three to four months, coinciding with routine diabetes clinic visits. Data collected were hemoglobin A1c,
number of patient-initiated contacts with the diabetes
team between clinic visits, and type of contact (phone
or e-mail correspondence). Additionally, a questionnaire was completed at study entry to assess routine
practices with diabetes data download, data review,
and barriers to reviewing data.
Expecting 23% of patients to have A1c within
target, determined by clinic data from previous years,
we estimated a sample size, n = 180 accounting for
80% power and 5% alpha. Continuous variables were
summarized using means and standard deviations (SD)
or medians and interquartile ranges (IQR) for nonnormal distributions. Comparisons were made using
Mann-Whitney U tests, paired and unpaired t-tests,
and Pearson correlations. Categorical variables were
summarized using frequencies (%), and comparisons
were made using chi-square tests (or Fisher’s exact tests
when appropriate). Analyses were conducted using
SPSS v26 (IBM Corp., Armonk, NY), and p-values < 0.05
were considered statistically significant.

Results
The study comprised 176 participants, 54% male,
with a mean (SD) age of 12.9 (± 3.8) years. Baseline
characteristics are summarized in Table 1. The Median
(IQR) duration of T1DM was 6 (4, 9) years with a median (IQR) duration of pump use of 3.6 (2.3, 6.2) years.
54% of the study participants were using a continuous
glucose monitor at the time of study enrollment.
The mean (SD) A1C was 8.1% (± 1.0) and 28.5%
of study participants had a mean A1c within the target
≤ 7.5%. The mean frequency of patient-initiated contacts between clinic visits comparing the group with
A1C in target and the group with A1c not in target
was similar (1.17 vs. 1.20). There was no significant
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Table 1. Baseline data
All study participants Group 1: A1c within target Group 2: A1c NOT within target
n

176

52

124

13 (± 3.8)

12.5 (± 3.8)

13 (± 3.8)

Female

46

44.2

46.8

Male

54

55.8

53.2

Caucasian

96

96.2

96

Black

0.6

0

0.8

Indigenous

0.6

0

0.8

Other

2.8

3.8

2.4

6.7 (± 3.7)

6.4 (± 3.9)

6.9 (± 3.6)

6 (4, 9)

5.5 (3, 9)

6 (4, 9)

4.5 (± 3.1)

4.4 (± 3.8)

4.5 (± 2.7)

Median (IQR)

3.6 (2.3, 6.2)

2.8 (1.5, 6.1)

4 (2.5, 6.2)

Mean A1c (%)

8.1 (± 1.0)

7.0 (± 0.3)

8.5 (± 1.0)

Age, mean (± SD)
Gender (%)

0.82

Duration of T1DM diagnosis
Median (IQR)

0.3
0.76

Ethnicity (%)

Mean (SD)

P

0.25

Duration of pump use
Mean (SD)

Pump type (%)

0.07
0.35
0.07

Medtronic

80.1

71.2

83.9

Omnipod

15.3

25

11.3

Animas

4.5

3.8

4.8

95 (54)

30 (32)

65 (68)

CGM use (%)
Libre, Dexcom or Guardian

0.633

CGM — continuous glucose monitoring; IQR — interquartile ranges; SD — standard deviation; T1DM — type 1 diabetes mellitus

Table 2. Comparison of A1c within target with mean # of contacts/person at different time points during the study

Time

1 a:

n (%)

Time 1: Mean # of contacts/person
Time

2a:

n (%)

Mean # of contacts/person
Time 3a: n (%)
Mean # of contacts/person
aTime

Group 1: A1c within target

Group 2: A1c NOT within target

49 (28)

125 (72)

1.35

1.34

51 (29)

124 (71)

1.12

1.09

32 (29)

77 (71)

1.03

1.19

0.88
0.69
0.93

1 — data between visit 1 and visit 2; time 2 — data between visit 2 and visit 3; time 3 — data between visit 3 and visit 4

correlation between A1c within target and frequency
of contact at any of the 4 time points (Tab. 2). The
initial A1c at study entry was 8.06% with a final A1c of
8.13%. There was no significant difference in change
in A1c (p = 0.35). The preferred method of contact in
this study population was e-mail at 90%, followed by
both phone and e-mail at 9%, and then phone at 1%.
There was a negative correlation between age and
mean number of contacts (r = –0.20, p = 0.01). There
was also a negative correlation between the duration of pump use and the mean number of contacts
(r = –0.17, p = 0.02). There was no significant re-
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P

lationship between distance from the hospital and
frequency of contact (r = 0.08, p = 0.30). The most
common barrier to diabetes data review identified by
study participants was “being too busy” (41%). Other
barriers were technical problems with software (39%)
and limited access to the internet (3%). Thirteen percent of study participants chose a free text option to
identify barriers. Common themes were forgetting,
being distracted, uncertain/afraid to make mistakes.
On the assessment of the frequency of blood
glucose review by self-report on the questionnaire,
6% of patients never reviewed, 30% reviewed prior
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to appointment, 18 % reviewed once a month. 21%
reviewed every 2 to 3 weeks, 9% reviewed weekly and
21% reviewed daily. Changes to insulin pump settings
were self-reported as being made by the patients 14%,
caregiver 47%, and the diabetes team 66%, with some
study participants choosing more than one option.

Discussion
There was no association between the frequency of
patient-initiated contact with the diabetes team among
patients using pump therapy and A1c within target in
our pediatrics diabetes clinic. However, the frequency of
contact in this study population was low regardless of
whether A1c was within target, with an average of 1.2
contacts in three to four months. Most studies showing
an improvement in A1c associated with diabetes team
contact had a minimum of one contact per month [1,
3, 9]. In view of the low frequency of patient-initiated
contact in this study population, the lack of an association
of contacts with A1c was not unexpected. Rather, this
study highlights the need to increase patient and family
engagement with the diabetes team between clinic visits.
A pediatric study spanning 6 months with frequent
contact of either daily, 2–3 times per week or twice
a month showed a significant change in A1c from
8.30 ± 1.1.6% to 7.45 ± 0.87% [9]. The mean age of
the study participants was 10.9 years and 17% were
on pump therapy. Contact was by WhatsApp (57%),
phone (29%), and by short message service (13%)
[9]. This study demonstrated the impact frequency of
contact can have on glycemic control but also showed
patient engagement to be a contributing factor to the
frequency of contact. Eighty-nine percent of individuals
with A1c < 7.5% consulted the diabetes team frequently, whereas only 23% of individuals with A1c > 9%
consulted frequently [9]. Highly motivated families
were found to have a higher frequency of contact. In
contrast, a randomized pediatric trial with an intervention of a bimonthly 15- to 30-minute phone call for
7 months duration did not show a difference in A1c [10].
There were concerns about lack of patient engagement
as a contributing factor.
Insulin pumps, continuous glucose monitoring,
and smart glucose monitoring are valuable devices and
options for patients with T1DM; however, they require
a moderate level of diabetes literacy and problem-solving
skills for optimal use and glycemic control [11]. A randomized controlled pediatric trial incorporated three
different texting contact topics: general information
messages on diabetes, interactive component weekly
reviewing data and collaborating with the family on
insulin dose adjustments, and multimedia video clips on
procedures such as pump site changes [12]. This study

showed not only a significant decrease in A1c, fasting
blood glucose, and post-prandial blood glucose, but
also an increase in parents’ diabetes knowledge test
scores [12]. In our study questionnaire, some patients
highlighted concerns and fears of making insulin dose
adjustments as a barrier to data review. Research suggests that this barrier can be mitigated by contact with
the diabetes team between clinic visits [12].
Increasing age and increasing duration of pump
use were associated with a lower frequency of contact
with the diabetes team in our study. There are unique
challenges to diabetes care in younger patients, most
notable with respect to insulin dosing and fear of
hypoglycemia [13]. Patients with longer duration of
pump use have longer experience with T1DM management and might be expected to be more comfortable with pump use and adjustments. However, this
study’s self-reported data showed that study participants, even those with longer duration of T1DM,
infrequently made pump adjustments between clinic
visits. There was a wide range of frequency of diabetes
data review between clinic visits, with 50% reviewing
either once a month, prior to a clinic appointment, or
never. Also, 66% of study participants reported pump
adjustments being made by the diabetes team. Conversely, 61% of study participants (14% patients and
47% caregivers) reported making pump adjustments.
The most commonly reported barrier to diabetes data
review and patient-initiated adjustments was “being
too busy”. These results emphasize the importance of
active patient engagement and consideration of the
time required by families for optimal diabetes care.
There have been several studies assessing the mode of
contact between clinic visits with patients [9, 14]. The
preferred mode of contact in our study was e-mail at
90%; however, other studies have found text messages
to be preferred over e-mail due to its convenience and
fast correspondence [9, 14]. Unfortunately, a secure
method of text messaging between patients and the
diabetes team was not available at our diabetes clinic;
this should be considered in future research.
A limitation of this study was continuous glucose
monitoring (CGM) data, such as time in range was not
collected. The study population was 96% Caucasian,
thereby limiting the generalizability.

Conclusions
In conclusion, this study did not show a correlation between the frequency of diabetes team contact
and A1c within target. Increasing age and increasing
duration of pump use was associated with reduced
frequency of contact in this study population. There
were variable rates of diabetes data review and insulin
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pump adjustments in between clinic visits. This study
highlights the importance of engagement of patients
with diabetes between clinic visits. Patients should be
empowered to make self-directed changes to insulin
pump settings between clinic visits. For patients requiring additional support or with poor glycemic control,
consideration should be given to developing an individual structured plan for frequent scheduled contact
with the diabetes team between clinic visits.
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